Gestational and perinatal outcomes in recurrent miscarriages couples treated with lymphocyte immunotherapy

Objective: This study aims to elucidate which types of recurrent miscarriage (RM) patients experienced a livebirth after paternal lymphocyte immunotherapy (LIT) and to evaluate the perinatal outcome. Study design: Retrospective analysis of a multicenter, observational study which enrolled 1096 coupl...

Full description

Saved in:
Bibliographic Details
Main Authors: Manoel Sarno (Author), Marcelo Borges Cavalcante (Author), Marla Niag (Author), Kleber Pimentel (Author), Ivana Luz (Author), Bianca Figueiredo (Author), Tatiana Michelon (Author), Jorge Neumann (Author), Simone Lima (Author), Isabela Nelly Machado (Author), Edward Araujo Júnior (Author), Ricardo Barini (Author)
Format: Book
Published: Elsevier, 2019-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_07317a0306c141c78d8d79c0e4080b49
042 |a dc 
100 1 0 |a Manoel Sarno  |e author 
700 1 0 |a Marcelo Borges Cavalcante  |e author 
700 1 0 |a Marla Niag  |e author 
700 1 0 |a Kleber Pimentel  |e author 
700 1 0 |a Ivana Luz  |e author 
700 1 0 |a Bianca Figueiredo  |e author 
700 1 0 |a Tatiana Michelon  |e author 
700 1 0 |a Jorge Neumann  |e author 
700 1 0 |a Simone Lima  |e author 
700 1 0 |a Isabela Nelly Machado  |e author 
700 1 0 |a Edward Araujo Júnior  |e author 
700 1 0 |a Ricardo Barini  |e author 
245 0 0 |a Gestational and perinatal outcomes in recurrent miscarriages couples treated with lymphocyte immunotherapy 
260 |b Elsevier,   |c 2019-07-01T00:00:00Z. 
500 |a 2590-1613 
500 |a 10.1016/j.eurox.2019.100036 
520 |a Objective: This study aims to elucidate which types of recurrent miscarriage (RM) patients experienced a livebirth after paternal lymphocyte immunotherapy (LIT) and to evaluate the perinatal outcome. Study design: Retrospective analysis of a multicenter, observational study which enrolled 1096 couples with a history of two or more spontaneous miscarriages without any intercalated delivery. We conducted an intention-to-treat analysis of couples with RM treated with or without LIT regarding to gestational and perinatal outcomes. We compared groups by using the Student's t-test or Kruskal-Wallis test, Fisher's exact-test and χ2 test when appropriate. Results: The success of gestation was significantly higher in the LIT group (60.1% vs. 33.1%; p <  0.001). A sub-analysis of four different immune disorder groups revealed a significantly higher success in the LIT group in all immune categories, except in patients who had autoantibodies positive. We observed no significant differences in perinatal outcomes such as gestational age at birth, preterm and extreme preterm birth, and birth weight in successful pregnancy in both groups. The success rate was significantly higher when LIT was administrated before and during pregnancy and only during pregnancy compared to only before pregnancy (p <  0.01). Conclusions: Careful laboratory test phenotyping of RM patients may identify subgroups most likely to benefit and exclude those with little likelihood of benefit, and LIT during a pregnancy may significantly improve success rates. Keywords: Lymphocyte immunotherapy, Recurrent miscarriage, Gestation, Perinatal outcomes 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n European Journal of Obstetrics & Gynecology and Reproductive Biology: X, Vol 3, Iss , Pp - (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2590161319300717 
787 0 |n https://doaj.org/toc/2590-1613 
856 4 1 |u https://doaj.org/article/07317a0306c141c78d8d79c0e4080b49  |z Connect to this object online.